baber/WOPTO huggingface dataset:
Patent ES-556913-A0 (ES)
IPC: B29L31/26
Filed: 1986-06-23
Abstract: The aparatus comprises a plastic material batching carousel (3) carrying a plurality of shuttles, and elements which take and leave batches of plastic material therein supplied by an extruder (2). A first star wheel (6) transfers shuttles having batches placed therein towards a forming carousel (4) where the batches of plastic material are pressed to form round gaskets (13). A second star wheel (7) is adapted to transfer shuttles with the molded gaskets (13) towards a further carousel (5), where elements are provided to extract the round gaskets (13) from the shuttles and to introduce them into cups (14). At the bottom of the inserting carousel (5) a star wheel (9) for moving away completed closures (15) and a star wheel (8) for transferring the evacuated shuttles towards the batching carousel (3) are provided.
Patent FI-833121-A0 (FI)
Inventor: EMMRICH PETER
IPC: B21D19/12
Filed: 1983-09-01
Abstract: 1. Apparatus for forming the beads (23, 23', 51, 51') and water-retaining folds (24, 24', 52, 52') by automatically curling and bending of the protruding, trimmed, free longitudinal edge protions (2, 2', 3, 3', 28, 28', 29, 29') on deepdrawn blanks (1, 27) for one-part gutter angles having side walls which are shaped like arcs of a circle adjacent to the corner joint between the abutting gutter angle members, characterized by a) a lower die having aa) a stationary lower die member (5, 31), which conforms to the exterior profile of the blank (1, 27) ; ab) a raising die member (13, 38), which is adapted to be raised and lowered and disposed on that side on which the water-retaining folds (24, 24', 52, 52') are to be formed. b) an upper die having ba) an upper die member (8, 33), which is adapted to be raised and lowered and conforms to the interior profile of the blank and is adapted to be clamped against the lower die member ; bb) a backing bar (10, 35) , which is adapted to be raised and lowered and disposed in a recess (1, 36) of the upper die member on the side on which the water-retaining fold is to be formed ; c) respective curling rods (20, 20', 48, 48'), which are longitudinally and transversely displaceable and are rotatable and adapted to be slidably fitted on the edges of those free longitudinal edge portions (2, 2', 29, 29' which are intended to form beads (23, 23', 51, 51') ; and d) respective bending rods (21, 21', 47, 47'), which are longitudinally displaceable and rotatable and adapted to be slidably fitted onto the edges of those free longitudinal edge portions (3, 3', 28, 28') which are intended to form the water-retaining folds (3, 3', 28, 28').
Patent FI-840686-A0 (FI)
Inventor: VAN DE KAMP DIETER
IPC: D03D1/00
Filed: 1984-02-20
Abstract: An endless loop article of manufacture comprises a core consisting essentially of at least one skein and a protective covering consisting essentially of hose fabric loosely enclosing said core, and a warp threading and a weft threading which latter comprises at least one monofilament thread extending transverse to the central loop axis, and preferably a monofilament and a multifilament thread arranged to run side by side. The protective covering comprises an endless toroidal part and an internal annular selvedge flange extending radially inwardly from the latter. A strap can be formed from such article of manufacture so deformed that opposite segments of the internal selvedge flange are brought into contact and sewn together, e.g. with an auxiliary warp thread, or by superimposing a protective layer to which the segments are sewn. The protective covering of the article can further comprise an external circumferential selvedge flange projecting radially outwardly from the toroidal part. From this kind of straps a mat can be formed by conventional methods.
Patent FI-841417-A0 (FI)
Inventor: DACOSTA NICHOLAS M
IPC: D06P1/28
Filed: 1984-04-10
Abstract: A hydrogel plastic article such as a soft contact lens is tinted by a water-insoluble vat dye which is physically locked into the hydrogel polymer as aggregates that are not individually discernible to the naked eye, and do not protrude beyond the surface of the article. In a soft contact lens, the aggregates may be concentrated near its convex face and only in an area approximating a human iris.
Patent FI-875072-A0 (FI)
Inventor: TOEMPE KARL
IPC: A45F4/08
Filed: 1987-11-17
Abstract: PCT No. PCT/AT86/00025 Sec. 371 Date Feb. 24, 1987 Sec. 102(e) Date Feb. 24, 1987 PCT Filed Mar. 28, 1986 PCT Pub. No. WO87/00013 PCT Pub. Date Jan. 15, 1987.A back-pack frame (1) intended for moving loads has longitudinal beams (3, 4) and cross beams (10, 13), carrying straps, load-securing elements, and coupling elements (17, 18) that make it possible to arrange two such back-pack frames (1) end-to-end, so as to form a platform that can be either carried or pulled along the ground. Four longitudinal beams (3, 4) are arranged so as to correspond approximately to the edges of a prism having a trapezoidal base, the longitudinal beams (3) being arranged at a greater distance from each other on the carrier side. The two load-side longitudinal beams (4) define a sliding plane, and on the two narrow sides of the back-pack frame (1) there is at least one holding element (6) for a shackle (7) that protrudes beyond the load-side longitudinal beams (4). On each carrier-side longitudinal beam (3) above the lowest element (6), there is at least one side-wall element (9) that is of flexible material. Side-wall elements (9) that are opposite each other on the two carrier-side longitudinal beams (3) are configured so as to be joinable to form a covering on either the load side or the carrier side. It is preferred that a slide plate (5) be arranged between the load-side longitudinal beams (4), the load-side longitudinal beams forming edge runners in the slide plate (5).
Patent FI-911319-A0 (FI)
Inventor: ALBERT RAINER
IPC: C07K14/54
Filed: 1991-03-18
Abstract: A biologically active peptide selected from growth factors, peptide hormones, interferons and cytokines and analogues and derivatives thereof, and bearing at least one chelating group linked to an amino group of said peptide, the chelating group being capable of complexing a detectable element and such amino group having no significant binding affinity to target receptors, are complexed with a detectable element and are useful as a pharmaceutical, e.g. a radiopharmaceutical for in vivo imaging of target tissues or for therapy.
Patent FI-930153-A0 (FI)
Inventor: STRAUB IMMANUEL
IPC: F16L21/06
Filed: 1993-01-14
Abstract: The pipe coupling has a housing (10) which can be constricted and in which the elastomer sealing collar (32) is arranged which has a C-shaped cross-section and sealing lips (36) extending towards one another. The meandering spring ring (44) which has a U-shaped cross-section and is provided with slots (74) is inserted into the respective annular groove (42) in order to support the sealing lip (36) on the collar web (34). When the housing (10) is constricted, the collar (32) is compressed in the circumferential sense and the sealing lips (36) rest smoothly on the pipe wall (55). At the same time, the spring ring (44) is constricted by the width of the slots (74) being reduced. The sealing lip (36) is supported by the spring ring (44) over a large area and the material of the collar (32) is prevented from flowing into and through the slots (74). The spring limb (68) which projects beyond the sealing lip (36) prevents the annular bead (56) sticking to the collar web (34). This pipe coupling is particularly suitable for use in the case of high operating temperatures and large temperature changes. 
<IMAGE>
Patent FI-941179-A0 (FI)
Inventor: HOOPES ROBERT J
IPC: C04B41/50
Filed: 1994-03-11
Abstract: A rehabilitative solution for preventing or retarding the spread of corrosion of metal reinforcements in concrete, comprising a) one or more corrosion-inhibiting agent(s) and b) a impregnation-increasing amount of a penetration-enhancing agent selected from the group consisting of C1 to C20 alcohols; alkali metal salts of gluconic acid; alkyl-substituted benzene compounds; or mixtures thereof, is disclosed, along with several methods of its application for concrete rehabilitation.
Patent FI-941538-A0 (FI)
Inventor: LANDH TOMAS
IPC: B01J13/02
Filed: 1994-03-31
Abstract: PCT No. PCT/SE92/00692 Sec. 371 Date Apr. 11, 1994 Sec. 102(e) Date Apr. 11, 1994 PCT Filed Oct. 2, 1992 PCT Pub. No. WO93/06921 PCT Pub. Date Apr. 15, 1993.Particles, especially colloidal particles, comprising an interior phase of a non-lamellar reversed cubic, intermediate or hexagonal liquid crystalline phase, or a homogeneous L3 phase, and a surface phase of a lamellar crystalline or liquid crystalline phase, or an L3 phase. A method of preparing such particles by creating a local dispersible phase, within the homogeneous phase, preferably by means of a fragmentation agent, and fragmentating the homogeneous phase so as to form said surface phase. Several medical as well as non-medical uses of the particles referred to, e.g. as an antigen-presenting system, as a delivery system for anticancer, antifungal and antimicrobial drugs, and as carriers of nucleic acids or nucleotides.
Patent FI-944045-A0 (FI)
Inventor: KLAUS MICHAEL
IPC: A61K31/215
Filed: 1994-09-02
Abstract: The compounds of the formula <IMAGE>  wherein R<1> is a radical of the formulae <IMAGE> and R<2>-R<10> have the meaning mentioned in the description, can be used as medicaments, particularly for dermatological and oncological indications.
Patent FI-950648-A0 (FI)
Inventor: GUENTHER WERNER
IPC: A61B6/14
Filed: 1995-02-14
Abstract: A dental x-ray diagnostics installation for producing panorama x-ray exposures of the skull of a patient has a rotary unit and a positioning unit mounted so as to be pivotable boom-like around a horizontal axle shaft and are arranged so as to be fixable in individual swiveled positions. The individual swiveled positions thereby correspond to different physical sizes of a seated patient. For preparing an exposure, the positioning unit is first adjusted to the patient and the rotary unit is subsequently adjusted in a fixed allocation to the positioning unit.
Patent FI-956289-A0 (FI)
Inventor: MICHIELS VEGA WILFRIED
IPC: C08F4/659
Filed: 1995-12-28
Abstract: The process is characterised by the use of catalyst systems consisting of a single metallocene catalyst activated with mixtures of at least 2 co-catalysts. The co-catalysts are aluminium alkyls, aluminoxanes or boron compounds. Different active centres are produced in the catalyst through the use of these mixed co-catalyst systems, each having different rates of initiation and completion of the polymerisation reaction, which give rise to polyolefins with different molecular weights, resulting in products with broad bimodal or multimodal molecular weight distributions and the incorporation of co-monomer can be controlled by appropriate selection of the metallocene and use of combinations of different types of co-catalysts, as well as by varying the reactor pressure, the reaction temperature and the molar ratios between the various components of the catalyst system. A broad bimodal or multimodal molecular weight distribution can be achieved in both the presence and absence of hydrogen during the polymerisation reaction. Likewise broad bimodal and multimodal molecular weight distributions can be obtained in polymers by varying the order in which the components of the catalyst system are added. This process may also be used with both homogeneous and heterogenous metallocene catalysts. <IMAGE>
Patent FI-962533-A0 (FI)
Inventor: FORSMAN BERTIL
IPC: F25B25/00
Filed: 1996-06-18
Abstract: PCT No. PCT/SE94/01222 Sec. 371 Date Jun. 13, 1996 Sec. 102(e) Date Jun. 13, 1996 PCT Filed Dec. 19, 1994 PCT Pub. No. WO95/17636 PCT Pub. Date Jun. 29, 1995A cooling system of compact design includes redundancy and free cold source usage. The system includes two circuits for circulating coolant and heat absorbing medium, and two heat exchanges common to the circuits. The heat exchangers are combined to act on both of the circuits, so that inside air is cooled by cold liquid or by expanding coolant in a combined evaporator-air cooler, and the outside air is used to cool warmed liquid or condensed coolant in a combined condenser-liquid cooler. Free cold, that is, outside cold air, may be utilized when the difference in temperature between inside air and outside air is sufficiently great and the outside air is sufficiently cold. Liquid cooled by outside air in the combined condenser-liquid cooler and then heated by warm inside air in the combined evaporator-air cooler can satisfy the entire heat load. In other cases, the compressor system can provide cooling. The free-cooling system can serve as a redundant system for the compressor system.
Patent IL-73071-A0 (IL)
Title: Substituted beta-carbolines,process for the preparation thereof,and use thereof as medicinal agents
IPC: A61P25/00
Filed: 1984-09-26
Abstract: Novel substituted  beta -carboline derivatives of Formula I <IMAGE>  (I)  wherein R3 is an oxadiazolyl residue of the formula <IMAGE>   wherein R5 stands for lower alkyl of up to 3 carbon atoms or an ester   <IMAGE>   with R6 being hydrogen or lower alkyl of up to 3 carbon atoms, R4 is hydrogen, lower alkyl of up to 3 carbon atoms, or CH2OR9 wherein R9 is lower alkyl of up to 3 carbon atoms, RA is phenyl or a hydrocarbon residue containing 2-10 carbon atoms which can be cyclic or acyclic, saturated or unsaturated, branched or unbranched, and which can optionally be substituted by oxo, formyl OH, O-alkyl of up to 3 carbon atoms or phenyl, and wherein, in a cyclic hydrocarbon residue, a CH2-group can be replaced by oxygen, exhibit an effect on the central nervous system and thus are suitable as psychopharmaceuticals.
Patent IL-80156-A0 (IL)
Title: Pharmaceutical compositions of the type which undergoes liquid-gel phase transition
IPC: C12P13/04
Filed: 1986-09-25
Abstract: The present invention relates to a pharmaceutical composition intended for contacting with a physiological liquid characterized in that said composition is intended to be administered as a non-gelled liquid form and is intended to gel in situ, this composition containing at least one polysaccharide in aqueous solution, of the type which undergoes liquid-gel phase transition gelling in situ under the effect of an increase in the ionic strength of said physiological liquid.
Patent IL-84364-A0 (IL)
Title: 4-hydroxy-4-(substituted alkenyl)-cyclohexanecarboxylic acids,process for their preparation and pharmaceutical compositions containing same
IPC: C07C67/00
Filed: 1987-11-04
Abstract: Compounds of the formula: <CHEM> wherein n is an integer from 0 to 2; R is straight-chain alkyl containing from 6 to 15 carbon atoms; X is hydrogen or, when n is 1 or 2, X can be -NH2; Y is hydroxy, -0- (C1-C4)alkyl, -NH2, -NH(C1-C4)alkyl , -N-(C1-C4)alkyl)2 or -NH-@@-COOH   wherein R' is hydrogen, alkyl of 1 to 4 carbon atoms, or benzyl; and Z is hydroxy, -O-(C1-C4)alkyl), -NH2, -NH-(C1-C4)alkyl , or -N-(C1-C4)alkyl)2, can be used in pharmaceutical composition. They may be prepared by reacting <CHEM>  with:   HS-(CH2)n-@@-@-Y' f
Patent IL-84526-A0 (IL)
Title: Condensate diamond
IPC: C30B25/02
Filed: 1987-11-19
Abstract: A mixture of hydrogen and methane gases is subjected to combined thermal heating and microwave radiation to form a gas plasma which is caused to condense on a substrate as diamond form of carbon.
Patent IL-99046-A0 (IL)
Title: Application of crosslinked crystals as a form of enzyme immobilization
IPC: G01N33/531
Filed: 1991-08-01
Abstract: A method of immobilizing an enzyme by forming crystals of the enzyme and, generally, also cross-linking the resulting crystals through the use of a bifunctional reagent; crosslinked, immobilized enzyme crystals (CLECs) made by this method; lyophilization of CLECs made by this method; lyophilized crosslinked immobilized CLECs and a method of making a desired product by means of a reaction catalyzed by a CLEC or set of CLECs.
Patent SE-9202540-A0 (SE)
Title: Sätt att vid återvinning av polyeten med flera polyolefiner ur returmaterial rena polyolefiner från mikroorganismer, särskilt sporer, och andra föroreningar
Inventor: LJUNGBO SVEN
IPC: C08J11/08
Filed: 1992-09-04
Abstract: •••• • • • • •• Sammandrag. ..... • • • • •• •• ••• ••• ••• • • : :••• •■•• • ••• • .• •
Patent SE-9600964-A0 (SE)
Title: Absorberande respektive uppbärande alster
Inventor: JOHANSSON ANNA-KARIN
IPC: A61F13/84
Filed: 1996-03-13
Abstract: SUKANDE (norm; och adieus) MOLNLYCKE AB 405 0 3GOTEBORG - NORENS PA'TENTBYRA AB 1040$100 55 crelna4011.4 sem OMBUD (mann) Tekn.Dr. Berth Ortenblad Civ,Ing. Jan-Clof Hyltner Fil.kand. Else Nor6n noe.ck Hansen UPPFINNARE (mann, art och land) Anna-Karin Johansson Moinlycke Sverige UPPFINNINGENS BENAMNING Absorberande respektive uppbarande alster BEGARAN OM PRIORITET (datum. land oar nurnmer) STAMANSUKNINGENS NUMMER: BEGARD GILTIGHETSDAG: ...... Vid avdelad tiler utbruten ansiikan BILAGOR: 2 Beskrivning i S exemplar Di2ritningsblad i 3 exemplar at Patentkrav i 3 exemplar [21 Sammandrag i anslutning till DI Overlitelschandling 13 Fullmakt CI LInderfullmakt lE) Ullindsk text 123 AvgiftSEK1600 0 Prioritctshaadling 0 ScItholin den1 3 mars 0.96 fig. 2\ i4t5LNLYE AB 3/at Underskriftenl54/93 + ITS granskning 2 000 = SEX 3 600 .—
Patent AU-PM859894-A0 (AU)
Title: Syringe
IPC: A61M5/32
Filed: 1994-10-04
Abstract: PCT No. PCT/AU95/00650 Sec. 371 Date Mar. 26, 1997 Sec. 102(e) Date Mar. 26, 1997 PCT Filed Oct. 4, 1995 PCT Pub. No. WO96/10433 PCT Pub. Date Apr. 11, 1996A syringe comprising a tubular body (11) closed at one end (12) and open at the other end (13), a plunger (14) receivable in the body (11) to define a chamber (16) of variable volume, a needle support (24) adapted to support and accommodate a hollow needle, said needle support (24) being supported from or in the wall of the body (11) and being movable in a direction substantially parallel to the main axis of the body (11) between a first position at which the needles extends from the one end of the body (11) and the interior of the needle is in communication with the chamber (16), and a second position at which the outer end of the needle is in a retracted position, said needle support (24) having a protrusion (28) which is selectively engageable with the wall of the body (11) at the first and second positions to be able to be retained at said positions and receivable through the wall of the body (11) when at the second position to be engaged with the plunger (14) to prevent axial movement of both the needle support (24) and the plunger (14) with respect to the body (11).
Patent AU-PQ616200-A0 (AU)
Title: Chemical metering pump
IPC: B67D7/00
Filed: 2000-03-10
Abstract: A liquid delivery system includes a first reservoir having a first outlet through which liquid is delivered. A first delivery outlet is located at the lower portion of the first reservoir and a vent is included at its upper portion. A second reservoir located above the first reservoir and has a second outlet located in its lower portion. A first delivery conduit connects the second outlet to the first reservoir and a second delivery conduit connects the upper portion of the first reservoir with the upper portion of the interior of the second reservoir. A vent valve controls communication through the second delivery conduit. A level sensor senses the level of liquid in the first reservoir and causes the vent valve to open when the liquid falls below a first predetermined level and to close the vent valve when on the level rises above a second (higher) predetermined level.
Patent IL-101052-A0 (IL)
Title: Glyceraldehyde-3-pentanide and process for producing same
IPC: C07D317/26
Filed: 1992-02-24
Abstract: The invention discloses glyceroldehyde 3-pentanide of formula: <CHEM> process for its production and intermediates for these processes of formula: <CHEM> Glyceroldehyde 3-pentanide is useful as a pharmaceutical and agricultural intermediate.
Patent IL-102857-A0 (IL)
Title: Compositions and methods for the sublingual or buccal administration of therapeutic agents
IPC: A61K47/12
Filed: 1992-08-18
Abstract: Pharmaceutical compositions for the sublingual or buccal administration of therapeutic agents (particularly polypeptides) which are normally degraded upon oral administration comprise such a therapeutic agent, a solvent, optionally a cosolvent and/or hydrogel, and an oral mucosal membrane transport enhancing agent which is selected from the group consisting of essential and volatile oils and inorganic and organic acids.
Patent IL-107306-A0 (IL)
Title: Tricyclic compounds
IPC: C07D239/70
Filed: 1993-10-17
Abstract: PCT No. PCT/GB93/02281 Sec. 371 Date Jun. 28, 1995 Sec. 102(e) Date Jun. 28, 1995 PCT Filed Nov. 4, 1993 PCT Pub. No. WO94/11354 PCT Pub. Date May 26, 1994The invention relates to tricyclic compounds of formula (I)    <IMAGE>  (I)  wherein R1 is hydrogen, amino, (1-4C)alkyl, (1-4C)alkoxy, hydroxy-(1-4C)alkyl or fluoro-(1-4C)alkyl; R2 is hydrogen, (1-4C)alkyl, (3-4C)alkenyl, (3-4C)alkynyl, hydroxy-(2-4C)alkyl, halogeno-(2-4C)alkyl or cyano-(1-4C)alkyl; Ar is optionally-substituted phenylene, thiophenediyl, thiazolediyl, pyridinediyl or pyrimidinediyl; and R3 includes a group of the formula -NHCH(CO2H)-A1-Y1 wherein A1 is (1-6C)alkylene and Y1 is carboxy, tetrazol-5-yl, N-[(1-4C)alkylsulphonyl]carbamoyl, N(phenylsulphonyl)carbamoyl, tetrazol-5-ylthio, tetrazol-5-ylsulphinyl or tetrazol-5-ylsulphonyl; or pharmaceutically-acceptable salts or esters thereof; to processes for their manufacture; to pharmaceutical compositions containing them; and to their use as anti-cancer agents.
Patent IL-120081-A0 (IL)
Title: Assay for evaluating the receptor binding characteristics of amylin agonists and antagonists
IPC: A61K38/28
Filed: 1997-01-27
Abstract: Methods for identifying or screening or characterizing or assaying or isolating known or candidate agonists and antagonists of amylin, comprising binding assays utilizing preparations containing specific receptors for amylin. Membranes from the brain that contain high density receptors for amylin are particularly useful for the methods of this invention, and as a source of amylin receptors.
Patent IL-122614-A0 (IL)
Title: Packaging systems for human recombinant adenovirus to be used in gene therapy
IPC: C12N5/10
Filed: 1996-06-14
Abstract: The invention provides improved methods and products based on adenoviral materials which can advantageously be used in for instance gene therapy. In one aspect an adenoviral vector is provided which has no overlap with a suitable packaging cell line which is another aspect of the invention. This combination excludes the possibility of homologous recombination, thereby excluding the possibility of the formation of replication competent adenovirus. In another aspect an adenovirus based helper construct which by its size is incapable of being encapsidated. This helper virus can be transferred into any suitable host cell making it a packaging cell. Further a number of useful mutations to adenoviral based materials and combinations of such mutations are disclosed, which all have in common the safety of the methods and the products, in particular avoiding the production of replication competent adenovirus and/or interference with the immune system. Further a method of intracellular amplification is provided.